The direct medical costs of Huntington's disease by stage. A retrospective commercial and Medicaid claims data analysis

Journal of Medical Economics

Volumn 16, Issue 8, 2013, Pages 1043-1050

  Divino, Victoria ^a   Dekoven, Mitch ^a   Warner, John H ^b   Giuliano, Joseph ^b   Anderson, Karen E ^c   Langbehn, Douglas ^d   Lee, Won Chan ^a  

^a IQVIA   (United States)

^b CHDI MANAGEMENT CHDI FOUNDATION   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

Burden of disease; Claims analysis; Cost of illness; Costs of care; Health care costs; Huntington's disease; Retrospective

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; DATA ANALYSIS; DECUBITUS; DEMENTIA; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; DRUG COST; DYSPHAGIA; FALLING; FEEDING APPARATUS; FEMALE; GAIT DISORDER; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOME CARE; HOSPICE CARE; HUMAN; HUNTINGTON CHOREA; ICD-9-CM; INCONTINENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAID; NURSING HOME; OUTPATIENT CARE; PHYSIOTHERAPY; SPEECH THERAPY;

ADOLESCENT; ADULT; AGED; DISEASE PROGRESSION; FEMALE; HEALTH SERVICES; HUMANS; HUNTINGTON DISEASE; INSURANCE CLAIM REVIEW; INSURANCE, HEALTH; LONG-TERM CARE; MALE; MEDICAID; MIDDLE AGED; MODELS, ECONOMIC; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; UNITED STATES; YOUNG ADULT;

EID: 84880523793     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2013.818545     Document Type: Article

References (22)

1. Novak MJ, Tabrizi SJ. Huntington's disease. BMJ 2010;340:c3109
2. Spinney L. Uncovering the true prevalence of Huntington's disease. Lancet Neurol 2010;9:760-1
3. National Institute of Neurological Disorders and Stroke. What is Huntington's Disease?. National Institutes of Heath, Bethesda MD, 2012. http://www.ninds.nih.gov/disorders/huntington/huntington.htm. Accessed March 6, 2012
4. Cardoso F. Huntington disease and other choreas. Neurol Clin 2009;27: 719-36
5. Roos RAC. Huntington's disease: a clinical review. Orphanet J Rare Dis 2010;5:40
6. Shoulson IF, Fahn S. Huntington disease: clinical care and evaluation. Neurology 1979;29:1-3
7. Rosas HD, Reuter M, Doros G, et al. A tale of two factors: what determines the rate of progression in Huntington's disease?. A longitudinal MRI study. Mov Disord 2011;26:1691-7
8. Mayo Clinic. Huntington's disease. Treatment and drugs. Mayo Foundation for Medical Education and Research (MFMER), Rochester, MN, 2011. http://www.mayoclinic.com/health/huntingtons-disease/DS00401/DSECTION- treatments%2Dand%2Ddrugs. Accessed March 6, 2012
9. Murman DL, Chen Q, Colucci PM, et al. Comparison of healthcare utilization and direct costs in three degenerative dementias. Am J Geriatr Psychiatry 2002;10:328-36
10. McCabe MP, O'Connor EJ. A longitudinal study of economic pressure among people living with a progressive neurological illness. Chronic Illn 2009;5:177-83
11. Dubinsky RM. No going home for hospitalized Huntington's disease patients. Mov Disord 2005;20:1316-22
12. Thomson Reuters MarketScan Research Database. Thomson Reuters Healthcare, Inc., Ann Arbor, MI, 2012 http://thomsonreuters.com/products-services/ healthcare/healthcare-products/pharmaceuticals/epidemiology-res/mktscan-res-db. Accessed on January 12, 2012
13. Buck CJ. ICD-9-CM 2011 Professional Edition for Physicians, Vols 1&2: Compact: 1st edn. American Medical Association, Chicago, IL. 2010
14. Bureau of Labor Statistics. Consumer Price Index. Washington, DC, 2011. http://www.bls.gov/cpi. Accessed on October 1, 2011
15. Costa N, Derumeaux H, Rapp T, et al. Methodological considerations in cost of illness studies on Alzheimer disease. Health Econ Rev 2012;2:18
16. Joyce AT, Zhao Y, Bowman L, et al. Burden of illness among commercially insured patients with Alzheimer's disease. Dement 2007;3:204-10
17. Prescott JD, Factor S, Pill M, et al. Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database. J Manag Care Pharm 2007;13:44-52
18. Huse DM, Schulman K, Orsini L, et al. Burden of illness in Parkinson's disease. Mov Disord 2005;20:1449-54
19. Fillit H, Hill JW, Futterman R. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy. Fam Med 2002;34:528-35
20. Gilden DM, Kubisiak J, Zbrozek AS. The economic burden of Medicareeligible patients by multiple sclerosis type. Value Health 2011;14:61-9
21. Dworkin RH, White R, O'Connor AB, et al. Health care expenditure burden of persisting herpes zoster pain. Pain Med 2008;9:348-53
22. van Dijk JG, van der Velde EA, Roos RA, et al. Juvenile Huntington Disease. Hum Genet 1986;73:235-9